Provided by Tiger Trade Technology Pte. Ltd.

BioCardia

1.23
+0.04003.36%
Pre-market: 1.22-0.0096-0.78%07:44 EDT
Volume:519.88K
Turnover:651.83K
Market Cap:18.62M
PE:-1.66
High:1.29
Open:1.19
Low:1.19
Close:1.19
52wk High:2.05
52wk Low:0.7500
Shares:15.14M
Float Shares:12.12M
Volume Ratio:2.51
T/O Rate:4.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7393
EPS(LYR):-1.2341
ROE:-1803.19%
ROA:-134.97%
PB:6.90
PE(LYR):-1.00

Loading ...

BioCardia CEO Peter Altman Presents at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 10

BioCardia CEO Peter Altman Buys 800 Shares for $872

Reuters
·
Sep 05

BioCardia Price Target Maintained with a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 25

BioCardia: Advancing Regulatory Momentum in Helix Catheter and CardiAMP HF Programs Supports Buy Rating and Unchanged $25 Price Target

TIPRANKS
·
Aug 24

BioCardia gets FDA confirmation of Helix meeting minutes

TIPRANKS
·
Aug 24

BioCardia Advances Helix Catheter Toward De Novo Approval

TIPRANKS
·
Aug 24

BioCardia Announces FDA Confirms Helix Transendocardial Delivery Catheter Meeting Minutes Supporting Follow-on De Novo Pre-Submission for Approval

THOMSON REUTERS
·
Aug 24

BioCardia - to Submit Follow-on Pre-Submission for Helix This Quarter

THOMSON REUTERS
·
Aug 24

BioCardia Receives Nasdaq Notice on Minimum Bid Price

TIPRANKS
·
Aug 22

BioCardia Receives NASDAQ Notice for Trading Below $1 Minimum Bid Price Requirement

Reuters
·
Aug 22

BioCardia CEO Peter Altman Acquires 5,400 Common Shares Worth $5,022

Reuters
·
Aug 19

Nasdaq Listing Risks: Potential Delisting Threatens Biocardia’s Market Access and Financial Stability

TIPRANKS
·
Aug 14

BioCardia CEO Peter Altman Acquires Common Shares Worth $1,748 in Open Market Purchase

Reuters
·
Aug 14

HeartBeam Q2 Loss Per Share Narrows; Co Lowers FY Net Operating Cash Outflow Guidance

Reuters
·
Aug 14

BioCardia Earnings Call Highlights Regulatory Momentum

TIPRANKS
·
Aug 13

BioCardia Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Sera Prognostics Q2 Revenue Rises on Expanded Partnerships and Medicaid Coverage

Reuters
·
Aug 13

BioCardia Q2 FY26 Net Loss Narrows to $1.61 Million; Cash Rises to $4.12 Million as of June 30, 2026

Reuters
·
Aug 13

BioCardia Q2 EPS $(0.13) Beats $(0.18) Estimate

Benzinga Earnings
·
Aug 13

BioCardia, Inc. Q2 Net Income USD -1.613 Million

Reuters
·
Aug 13